Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Heart surgeons may deliver better outcomes during stressful procedures
Excessive stress may still be harmful to a surgeon's performance, researchers warned, but moderate stress early on during a procedure appears to reduce the odds of a major complication.
Aortic valve calcium scores help predict need for a permanent pacemaker after TAVR
RBBB remains the single strongest predictor for PPMI after TAVR, but high AV calcium scores still provide care teams with considerable value.
Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say
The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%.
Congressional candidate physician sues hospital and doctor for death of father
Some of the claims in the lawsuit, brought against Novant Health by Kyle Horton, MD, are backed by a report from the North Carolina Department of Health and Human Services.
Diabetes reduces survival after SAVR, but not TAVR
"TAVR has been associated with better valve hemodynamics and a lower risk of structural valve deterioration over time compared with SAVR," researchers wrote. "This benefit may be particularly relevant for diabetes patients who face higher risks of vascular complications."

Landmark discovery provides clinicians with a ‘valuable clinical tool’ for diagnosing myocarditis

Researchers believe they have found the first blood biomarker for diagnosing myocarditis, sharing their findings in the New England Journal of Medicine.

Cardiac arrest numbers highlight the pandemic’s long-term impact on patient care

Researchers will be tracking COVID-19's impact on healthcare for many years to come.

Dapagliflozin a cost-effective treatment for HFrEF at its current price point

Researchers found that the SGLT2 inhibitor had similar value among patients with and without diabetes, sharing their findings in JAMA Cardiology.

Cancer patients after PCI: Key statistics every cardiologist should know

Researchers examined data from nearly 1,200 PCI patients, sharing their findings in JACC: Cardiovascular Interventions.

Cardiologist shares a warning fish oil can no longer be considered harmless

After studying the latest research, a veteran cardiologist is no longer recommending fish oil supplements to his patients.

13% of TAVR patients develop acute kidney injury, increasing their risk of in-hospital mortality

Chronic kidney disease, congestive heart failure and liver disease are just some of the comorbidities associated with a greater risk of AKI.

Eating plant-based meals late in the day lowers risk of cardiovascular disease by 10%

It's not necessarily that people should never eat meat—but eating it for breakfast instead of dinner, for example, can make a significant difference.

Moderna vaccine safe in youth 12-17

Moderna’s COVID-19 vaccine is effective in young people between 12 and 17, according to results from phase two of three of the biopharmaceutical company’s study.

Clinical

Heart surgeons may deliver better outcomes during stressful procedures

Aortic valve calcium scores help predict need for a permanent pacemaker after TAVR

Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

Congressional candidate physician sues hospital and doctor for death of father

Diabetes reduces survival after SAVR, but not TAVR